Skip to main content
Top
Published in: Neurological Sciences 10/2017

01-10-2017 | Original Article

Glial and neuronal antibodies in patients with idiopathic intracranial hypertension

Authors: Güneş Altıokka-Uzun, Ece Erdağ, Betül Baykan, John Tzartos, Duygu Gezen-Ak, Bedia Samancı, Erdinç Dursun, Paraskevi Zisimopoulou, Katerina Karagiorgou, Christos Stergiou, Erdi Şahin, Esme Ekizoğlu, Murat Kürtüncü, Erdem Tüzün

Published in: Neurological Sciences | Issue 10/2017

Login to get access

Abstract

Headache and visual disturbances are the main presenting symptoms of idiopathic intracranial hypertension (IIH) characterized by increased intracranial pressure (ICP) with an unknown cause. We aimed to investigate the antibodies against optic neuritis-associated glial antigens, aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) and uncharacterized neuronal membrane antigens in IIH patients. Consecutive patients diagnosed according to Friedman revised diagnostic criteria and control subjects were included after their consent. All serum samples were analyzed for antibodies against AQP4 and MOG using cell-based immunofluorescent assays and for uncharacterized neuronal membrane antigens by indirect immunocytochemistry utilizing live neurons. Sera of 34 patients with IIH and 40 control subjects were investigated but none of the patients showed AQP4 and MOG antibodies. However, serum IgG of five IIH patients showed reactivity against membrane antigens of rat hippocampal and cortical neurons. Interestingly, three out of these five patients had nonspecific white matter lesions on MRI, whereas only four of all other patients had these lesions (p = 0.048). AQP4 and MOG antibodies do not seem to have a role in the pathophysiology of IIH. However, association of immunocytochemistry findings with the presence of white matter lesions may suggest that immunological factors contribute to the pathogenesis of IIH in at least some of the patients.
Literature
6.
go back to reference Edwards LJ, Sharrack B, Ismail A, Tench CR, Gran B, Dhungana S, Brettschneider J, Tumani H, Constantinescu CS (2013) Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol 2:234–244PubMedPubMedCentral Edwards LJ, Sharrack B, Ismail A, Tench CR, Gran B, Dhungana S, Brettschneider J, Tumani H, Constantinescu CS (2013) Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Am J Clin Exp Immunol 2:234–244PubMedPubMedCentral
7.
go back to reference Samanci B, Samanci Y, Tuzun E, Altiokka-Uzun G, Ekizoglu E, Icoz S, Sahin E, Kucukali CI, Baykan B (2016) Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension. Cephalalgia. doi:10.1177/0333102416650705 Samanci B, Samanci Y, Tuzun E, Altiokka-Uzun G, Ekizoglu E, Icoz S, Sahin E, Kucukali CI, Baykan B (2016) Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension. Cephalalgia. doi:10.​1177/​0333102416650705​
8.
go back to reference Altiokka-Uzun G, Tuzun E, Ekizoglu E, Ulusoy C, Yentur S, Kurtuncu M, Saruhan-Direskeneli G, Baykan B (2015) Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. Cephalalgia 35:1153–1161. doi:10.1177/0333102415570762 CrossRefPubMed Altiokka-Uzun G, Tuzun E, Ekizoglu E, Ulusoy C, Yentur S, Kurtuncu M, Saruhan-Direskeneli G, Baykan B (2015) Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension. Cephalalgia 35:1153–1161. doi:10.​1177/​0333102415570762​ CrossRefPubMed
10.
13.
go back to reference Ekizoglu E, Icoz S, Tuzun E, Birisik O, Kocasoy-Orhan E, Akman-Demir G, Baykan B (2012) Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalalgia 32:198–202. doi:10.1177/0333102411434167 CrossRefPubMed Ekizoglu E, Icoz S, Tuzun E, Birisik O, Kocasoy-Orhan E, Akman-Demir G, Baykan B (2012) Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalalgia 32:198–202. doi:10.​1177/​0333102411434167​ CrossRefPubMed
14.
go back to reference Doppler K, Schutt M, Sommer C (2016) Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Cephalalgia. doi:10.1177/0333102416630592 Doppler K, Schutt M, Sommer C (2016) Decreased levels of aquaporin-4 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. Cephalalgia. doi:10.​1177/​0333102416630592​
15.
go back to reference Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, Leiz S, Pohl D, Venkateswaran S, Pritsch M, Koch J, Schimmel M, Hausler M, Klein A, Blaschek A, Thiels C, Lucke T, Gruber-Sedlmayr U, Kornek B, Hahn A, Leypoldt F, Sandrieser T, Gallwitz H, Stoffels J, Korenke C, Reindl M, Rostasy K (2016) Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry 87:897–905. doi:10.1136/jnnp-2015-311743 CrossRefPubMed Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, Leiz S, Pohl D, Venkateswaran S, Pritsch M, Koch J, Schimmel M, Hausler M, Klein A, Blaschek A, Thiels C, Lucke T, Gruber-Sedlmayr U, Kornek B, Hahn A, Leypoldt F, Sandrieser T, Gallwitz H, Stoffels J, Korenke C, Reindl M, Rostasy K (2016) Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry 87:897–905. doi:10.​1136/​jnnp-2015-311743 CrossRefPubMed
17.
go back to reference Sadaba MC, Gonzalez Porque P, Masjuan J, Alvarez-Cermeno JC, Bootello A, Villar LM (2004) An ultrasensitive method for the detection of oligoclonal IgG bands. J Immunol Methods 284:141–145CrossRefPubMed Sadaba MC, Gonzalez Porque P, Masjuan J, Alvarez-Cermeno JC, Bootello A, Villar LM (2004) An ultrasensitive method for the detection of oligoclonal IgG bands. J Immunol Methods 284:141–145CrossRefPubMed
19.
go back to reference Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Jurynczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89. doi:10.1212/NXI.0000000000000089 CrossRefPubMedPubMedCentral Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Jurynczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89. doi:10.​1212/​NXI.​0000000000000089​ CrossRefPubMedPubMedCentral
20.
go back to reference Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi:10.1093/brain/awq113 CrossRefPubMedPubMedCentral Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667. doi:10.​1093/​brain/​awq113 CrossRefPubMedPubMedCentral
22.
go back to reference Dursun E, Gezen-Ak D, Yilmazer S (2013) A new mechanism for amyloid-beta induction of iNOS: vitamin D-VDR pathway disruption. J Alzheimers Dis 36:459–474. doi:10.3233/JAD-130416 PubMed Dursun E, Gezen-Ak D, Yilmazer S (2013) A new mechanism for amyloid-beta induction of iNOS: vitamin D-VDR pathway disruption. J Alzheimers Dis 36:459–474. doi:10.​3233/​JAD-130416 PubMed
23.
go back to reference Lyra TG, Martin Mda G, Carvalho Rdo C, Oliveira CR, Godoy LF, Delgado Dde S, Cerri GG, Leite Cda C (2013) Pseudotumoral presentation of primary central nervous system vasculitis. Arq Neuropsiquiatr 71:333–335CrossRefPubMed Lyra TG, Martin Mda G, Carvalho Rdo C, Oliveira CR, Godoy LF, Delgado Dde S, Cerri GG, Leite Cda C (2013) Pseudotumoral presentation of primary central nervous system vasculitis. Arq Neuropsiquiatr 71:333–335CrossRefPubMed
24.
go back to reference Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55:414–422. doi:10.1111/epi.12528 CrossRefPubMed Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55:414–422. doi:10.​1111/​epi.​12528 CrossRefPubMed
29.
go back to reference Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B and in cooperation with the Neuromyelitis Optica Study G (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280. doi: 10.1186/s12974-016-0718-0 Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B and in cooperation with the Neuromyelitis Optica Study G (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280. doi: 10.​1186/​s12974-016-0718-0
Metadata
Title
Glial and neuronal antibodies in patients with idiopathic intracranial hypertension
Authors
Güneş Altıokka-Uzun
Ece Erdağ
Betül Baykan
John Tzartos
Duygu Gezen-Ak
Bedia Samancı
Erdinç Dursun
Paraskevi Zisimopoulou
Katerina Karagiorgou
Christos Stergiou
Erdi Şahin
Esme Ekizoğlu
Murat Kürtüncü
Erdem Tüzün
Publication date
01-10-2017
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 10/2017
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-017-3066-7

Other articles of this Issue 10/2017

Neurological Sciences 10/2017 Go to the issue